Interpretation of guideline for diagnosis and treatment of liver failure （2024 version）
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 12
Abstract
In 2024， Liver Failure and Artificial Liver Group， Chinese Society of Infectious Diseases， Chinese Medical Association and Chinese Society of Hepatology， Chinese Medical Association updated Guideline for diagnosis and treatment of liver failure （2018 version）. Guideline for diagnosis and treatment of liver failure （2024 version） covers the definition and etiology of liver failure， the classification and diagnosis of liver failure， the treatment of liver failure， and future prospects. This article gives an interpretation of the updated key points in the new edition of the guideline， in order to better guide the management of liver failure in clinical practice.
Authors and Affiliations
Tao HAN
Keywords
Related Articles
- EP ID EP753956
- DOI 10.12449/JCH241207
- Views 5
- Downloads 0
Efficacy and safety of N-acetylcysteine in treatment of severe alcoholic hepatitis
[Objective] To investigate the efficacy and safety of N-acetylcysteine （NAC） in the treatment of severe alcoholic hepatitis （SAH）， and to provide a basis for clinical medication for SAH. [Methods] A prospective rand...
Research advances in chronic hepatitis B with metabolic dysfunction-associated steatotic liver disease
Chronic hepatitis B （CHB） and fatty liver disease are common chronic liver diseases in China. With the changes in lifestyle， the number of patients with CHB and metabolic dysfunction-associated steatotic liver disease...
Efficacy of transjugular intrahepatic portosystemic shunt in treatment of hepatocellular carcinoma comorbid with esophagogastric variceal bleeding
[Objective] To investigate the efficacy of transjugular intrahepatic portosystemic shunt （TIPS） in preventing rebleeding in patients with hepatocellular carcinoma （HCC） comorbid with esophagogastric variceal bleeding...
Pancreatic hamartoma： A case report
Pancreatic hamartoma is a rare benign lesion of the pancreas characterized by a lack of typical clinical symptoms and imaging features， which leads to the difficulty in diagnosis before surgery. Since surgical intervent...
Research advances of noninvasive diagnosis of fibrotic non-alcoholic steatohepatitis
A subset of patients with non-alcoholic fatty liver disease （NAFLD） can progress to nonalcoholic steatohepatitis （NASH）. When NASH reaches a fibrosis degree of F≥2 and a NAS score of≥4， this stage of NASH is referre...